Related Experiment Video
Updated: Aug 24, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Treatment strategies for patients with atrial fibrillation and chronic heart failure]
S N Tereshchenko1,2, T M Uskach1,2
1National Medical Research Center of Cardiology.
Insights
Atrial fibrillation (AF) and chronic heart failure (CHF) often coexist, worsening patient outcomes. This review details their prevalence, prognosis, and optimal management strategies, focusing on rhythm control and anticoagulation safety.
Area of Science:
- Cardiology
- Internal Medicine
Context:
- Atrial fibrillation (AF) and chronic heart failure (CHF) are prevalent cardiovascular conditions.
- These conditions frequently coexist, creating a complex clinical scenario with significant morbidity and mortality.
- The bidirectional relationship between AF and CHF necessitates tailored treatment approaches.
Purpose:
- To review the prevalence and prognostic implications of concurrent AF and CHF.
- To discuss current management strategies, including rhythm control and anticoagulation.
- To highlight the importance of safety, particularly bleeding risk, in anticoagulant therapy for these patients.
Summary:
- This article synthesizes data from meta-analyses on managing patients with both AF and CHF.
- It examines rhythm control strategies in AF with concomitant CHF, referencing recent studies and clinical guidelines.
- Key aspects of anticoagulant therapy, emphasizing safety and bleeding risk, are detailed.
Impact:
- Provides clinicians with updated insights into the complex interplay of AF and CHF.
- Informs treatment decisions regarding rhythm control and anticoagulation in this high-risk patient population.
- Underscores the critical need for balancing therapeutic efficacy with safety to improve patient outcomes.
Abstract:
Atrial fibrillation (AF) is associated with significant morbidity and mortality and may lead to the development of chronic heart failure (CHF). Each condition predisposes to the other, requiring a careful choice of the treatment strategy. This article is devoted to the prevalence and prognostic implications of both diseases. The article presents data from meta-analyzes related to the management of this group of patients. The aspects of rhythm control strategy in AF and concomitant CHF are described according to the recent studies and clinical guidelines. The features of anticoagulant therapy in patients with AF and CHF are outlined. Much attention is given to the importance of the safety profile of the anticoagulant therapy in terms of the bleeding risk in patients with concomitant AF and CHF.
More Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure Drugs: β-Blockers
Cardiomyopathy V: Interprofessional Care

